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INTRODUCTION
With recent development of molecular biology, cancer was
revealed as a genetic disease. Unlike other hereditary diseases,
cancer is a more complex genetic disease in that cancer does
not develop just with one gene abnormality but with many
genetic alterations that participate within one cell. 
Currently, most of solid tumors are known to occur with
the process of genetic alterations being accumulated in stages;
Fearon and Vogelstein suggested a multi-step progression
model of genetic alterations that participates in the initia-
tion and progression of colon cancer through the research on
the tumor progression from dysplastic polyp and adenoma
to adenocarcinoma (1).
We think that laryngeal squamous cell carcinoma (SCC)
also progresses through well-established clinical and histo-
pathological stages; and there have been many studies on
genetic alterations related to laryngeal SCC (2-4). However,
it is not clear yet which genes participate in histopathologi-
cal stages of laryngeal SCC.
Among many genes related to the development of tumors,
the putative tumor suppressor gene has the gene code on the
protein that suppresses cell growth and thus, is known to
suppress tumor formation; and inactivation of this gene plays
a definite role in the development and progression of tumors.
Loss of heterozygosity (LOH) is the most common phenome-
non in the inactivation of the putative tumor suppressor gene;
and LOH analyses have provided definite clues to confirm-
ing the position of putative tumor suppressor gene and study-
ing the process of cloning (5).
From the paraffin embedded tissues of larynx and cervical
lymph node obtained from the same larynx SCC patients,
the authors of the present study selectively separated the cells
of each stage, i.e. normal, squamous metaplasia, squamous
dysplasia, invasive SCC, and metastatic carcinoma of cervi-
cal lymph node, using the microdissection technique. We
tried to confirm the progressive stages of genetic alterations
related to the progression of laryngeal SCC.
MATERIALS AND METHODS
Materials
Twenty-two cases of laryngeal SCC with cervical lymph
node metastasis were selected from the clinical pathology
department of The Catholic University of Korea, College of
Medicine. All cases were confirmed to contain foci of squa-
mous metaplasia, squamous dysplasia, invasive SCC and meta-
static carcinoma in their pathologic materials.
Microdissection
Cells from the areas of squamous metaplasia, squamous dys-
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Loss of Heterozygosity on Chromosomes 3p, 8p, 9p and 17p in the
Progression of Squamous Cell Carcinoma of the Larynx 
Previous molecular genetic studies of laryngeal squamous cell carcinoma (SCC)
have shown certain chromosomal regions with recurring alterations. But studies of
sequential molecular alterations and genetic progression model of laryngeal SCC
have not been clearly defined. To identify the chromosomal alterations associated
with the carcinogenesis of laryngeal SCC, we analyzed genomic DNA from micro-
dissected squamous metaplasia, squamous dysplasia, invasive SCC, and metastat-
ic carcinoma samples from 22 laryngeal SCC patients for loss of heterozygosity
(LOH) at microsatellite loci. Ten microsatellite markers on chromosome 3p, 8p, 9p,
and 17p were used. LOH at 9p21 was observed in the all stages including squa-
mous metaplasia, squamous dysplasia, invasive SCC and metastatic carcinoma.
LOH at 17p13.1, 3p25 and 3p14.2 was observed from the squamous dysplasia,
invasive SCC and metastatic carcinoma. LOH at 8p21.3-p22 was observed main-
ly from the invasive SCC and metastatic carcinoma. The results suggest that 9p21
in the early event, 17p13.1, 3p25 and 3p14.2 in the intermediate event and 8p21.3-
p22 in the late event may be involved in the laryngeal carcinogenesis. 
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plasia, invasive SCC and metastatic carcinoma of the cervical
lymph nodes were selectively produced from H&E stained
slides without normal cell contamination using a 30 G nee-
dle (Fig. 1). We also obtained normal lymphocytes or sub-
mucosal glands for corresponding normal DNA from the
same cases. 
DNA extraction
DNA extraction was done by a modified single step DNA
extraction method. Procured cells (500 cells) in 20  L of
DNA extraction buffer containing 100 mM Tris-HCl, pH
8.0; 0.1% Tween 20 and 0.1 mg/mL proteinase K, were incu-
Fig. 1-1. Sections of laryngeal carcinoma (A) and metastatic lymph node (B) from case 4 showing the areas of metaplasia (M), dysplasia






Fig. 1-2. The magnified areas of metaplasia (M), dysplasia (D), invasive carcinoma (I ), and lymph node metastatic carcinoma (L) before
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bated at 52℃ for 1 day. The mixture was boiled for 10 min
to inactivate the proteinase K and 2  L of this solution were
used as DNA template for PCR amplification.
LOH analysis
DNA from each lesions and corresponding normal cells were
amplified by thermal cycler with ten microsatellite markers
(Research Genetics, Huntsville, AL) including IFNA, D9S171
and D9S104 on 9p21, TP53 on 17p13.1, D3S1038 on 3p25,
D3S1067 and D3S1234 on 3p14.2, D8S133, D8S261, D8-
S258 on 8p21.3-p22. Each PCR reaction was generally per-
formed in standard conditions in a 10  L of reaction mixture
containing 2  L of template DNA, 0.25  L each primers, 1.25
mM each dNTP 1  L, 1.5 mM MgCl2 0.5 L,  10×PCR
buffer 1  L, 0.4 U Taq polymerase 0.07  L (Perkin-Elmer,
Foster City, CA), and 10 mCi [32P] CTP 0.05  L. The reac-
tion mixtures were denatured at 95℃and incubated 32 cycles
(denaturing at 94℃ for 40 sec, annealing at 55℃ for 90 sec
and extending 72℃ for 90 sec) with some variations made
in the annealing temperature. Reaction products (8  L) were
denatured and electrophoresed in 6% polyacrylamide gels
containing 7 M urea. After electrophoresis, the gels were trans-
ferred to 3 mm Whatman paper then dried, and finally autora-
diography was performed using Kodak-OMAT film (Eastman
Kodak, Ochester, NY).
RESULTS
The results of LOH according to the microsatellite mark-
ers selected for the present study and histopathological stages
of each sample are shown in Table 1. The status of allelic loss
was compared between the normal cell, squamous metapla-
sia, squamous dysplasia, invasive SCC, and metastatic carci-
noma of lymph node from the same patients. LOH in case 2
and case 13 are shown in Fig. 2 and Fig. 3, respectively.
LOH analysis on chromosome 9p21 
LOH on IFNA, D9S171 and D9S104 was detected in
63.6% (7/11), 57.1% (4/7) and 50.0% (4/8), respectively.
Most of these cases except three cases showed LOH in all histo-
pathologic stages, from squamous metaplasia to metastatic
carcinoma. Two cases (case 1 in INFA and case 21 in D9S171)
among three cases showed LOH in squamous dysplasia, inva-
sive and metastatic carcinoma. Another case (case 12 in IFNA)
showed LOH in only invasive and metastatic carcinoma. From
these results, we guess the genetic alterations of 9p21 par-
ticipate when the normal cells transform to squamous meta-
plastic cells. Since p16ink4a gene is located between IFNA and
D9S171, a LOH on either of the two markers indicates a gene-
tic alteration on p16ink4a gene. And the presence of another
tumor suppressor gene around D9S104 is suggested.
M, metaplasia; D, squamous dysplasia; I, invasive carcinoma; L, lymph node metastasis; ●, loss of heterozygosity; ○, non-informative or homozy-
gote; ◎, negative for allele loss (retention of both informative alleles).
M D I L M D I L M D I L M D I L M D I L M D I L M D I L M D I L M D I L M D I L
IFNA D9S171 D9S104 TP53 D3S1038 D3S1067 D3S1234 D8S133 D8S261 D8S258
9p 17p 3p 8p
1 ◎●●● ○○○○ ○○○○ ○○○○ ○○○○ ○○○○ ◎●●● ◎●●● ○○○○ ○○○○
2 ●●●● ●●●● ●●●● ◎●●● ◎●●● ◎●●● ○○○○ ○○○○ ○○○○ ○○○○
3 ○○○○ ○○○○ ○○○○ ◎●●● ○○○○ ◎◎◎◎ ◎◎◎◎ ○○○○ ○○○○ ○○○○
4 ○○○○ ○○○○ ○○○○ ◎◎◎◎ ◎●●● ◎●●● ○○○○ ○○○○ ○○○○ ○○○○
5 ○○○○ ◎◎◎◎ ○○○○ ◎◎◎◎ ○○○○ ◎◎◎◎ ◎◎◎◎ ◎●●● ○○○○ ○○○○
6 ●●●● ●●●● ○○○○ ◎◎◎◎ ◎◎◎◎ ○○○○ ◎●●● ○○○○ ◎●●● ○○○○
7 ○○○○ ○○○○ ●●●● ○○○○ ◎◎◎◎ ◎◎◎◎ ◎◎◎◎ ○○○○ ○○○○ ◎◎●●
8 ◎◎◎◎ ○○○○ ◎◎◎◎ ◎●●● ◎●●● ○○○○ ◎●●● ◎◎◎◎ ○○○○ ◎◎◎◎
9 ●●●● ○○○○ ●●●● ○○○○ ◎●●● ◎◎◎◎ ○○○○ ○○○○ ○○○○ ◎◎◎◎
10 ○○○○ ○○○○ ○○○○ ○○○○ ○○○○ ◎●●● ◎●●● ○○○○ ◎◎●● ◎◎●●
11 ◎◎◎◎ ◎◎◎◎ ○○○○ ◎◎◎◎ ○○○○ ○○○○ ◎◎◎◎ ◎◎◎◎ ◎◎●● ◎●●●
12 ◎◎●● ○○○○ ○○○○ ◎◎◎◎ ○○○○ ◎◎◎◎ ◎●●● ◎◎◎◎ ◎●●● ○○○○
13 ○○○○ ●●●● ○○○○ ○○○○ ○○○○ ◎●●● ◎●●● ◎●●● ◎◎●● ◎◎●●
14 ◎◎◎◎ ○○○○ ●●●● ◎◎◎◎ ◎◎◎◎ ○○○○ ◎●●● ◎◎◎◎ ◎●●● ○○○○
15 ○○○○ ○○○○ ○○○○ ◎◎◎◎ ○○○○ ◎●●● ◎●●● ○○○○ ○○○○ ◎◎◎◎
16 ○○○○ ○○○○ ○○○○ ◎●●● ◎●●● ○○○○ ○○○○ ○○○○ ○○○○ ◎◎◎◎
17 ○○○○ ○○○○ ◎◎◎◎ ◎◎◎◎ ○○○○ ◎●●● ◎◎◎◎ ◎◎◎◎ ○○○○ ○○○○
18 ◎◎◎◎ ◎◎◎◎ ◎◎◎◎ ◎◎◎◎ ○○○○ ◎◎●● ◎●●● ◎◎●● ◎◎●● ◎◎◎◎
19 ●●●● ○○○○ ○○○○ ◎●●● ○○○○ ◎◎◎◎ ○○○○ ○○○○ ◎●●● ○○○○
20 ●●●● ○○○○ ○○○○ ◎◎◎◎ ◎●●● ◎●●● ◎●●● ◎◎●● ○○○○ ○○○○
21 ○○○○ ◎●●● ◎◎◎◎ ◎●●● ○○○○ ○○○○ ○○○○ ○○○○ ◎◎◎◎ ○○○○
22 ○○○○ ○○○○ ○○○○ ◎●●● ◎◎◎◎ ○○○○ ○○○○ ◎◎●● ○○○○ ◎◎●●
Table 1. Loss of heterozygosity on chromosome 9p, 17p, 3p and 8p in 22 laryngeal squamous cell carcinomas348 W.J. Yoo, S.H. Cho, Y.S. Lee, et al.
LOH analysis on chromosome 17p13.1
LOH on TP53 was detected in 7 (41.2%) of 17 informa-
tive cases from squamous dysplasia, invasive carcinoma and
metastatic carcinoma. There was no LOH in all 17 informa-
tive cases of squamous metaplasia. Thus, we guess that the
genetic alterations of 17p13.1 participate in the transforma-
tion from non-neoplastic stage to preinvasive neoplastic stage.
LOH analysis on chromosome 3p
D3S1038, on 3p25, showed no LOH in all 10 cases of squa-
mous metaplasia, showed LOH in 6 (60.0%) of 10 informa-
tive cases of squamous dysplasia, invasive carcinoma and meta-
static carcinoma. Thus, we guess that the genetic alterations
of 3p25 participate in the transformation to preinvasive neo-
plastic lesion. 
Also in D3S1067 and D3S1234 on 3p14.2, LOH was de-
tected in 57.1% (8/14) and 66.7% (10/15), respectively. All
cases except one case (case 18 in D3S1067) showed LOH in
squamous dysplasia, invasive carcinoma and metastatic car-
cinoma. In case 18, LOH was not present in squamous dys-
plasia, but observed in only invasive and metastatic carcino-
ma. Thus, we guess that the genetic alterations of 3p14.2
participate in the transformation to preinvasive neoplastic
stage. 
LOH analysis on chromosome 8p21.3-p22
LOH on D8S133 was detected in 6 (54.5%) of 11 infor-
mative cases. In all 11 informative cases, there was no LOH
in squamous metaplasia. Among these 6 cases, 3 cases showed
LOH in squamous dysplasia, invasive carcinoma and meta-
static carcinoma. Remaining 3 cases showed LOH in only
invasive carcinoma and metastatic carcinoma. 
LOH on D8S261 was observed in 8 (88.9%) of 9 infor-
mative cases, and 4 of these 8 cases showed LOH in invasive
carcinoma and metastatic carcinoma, and not in squamous
Fig. 2. Analysis of loss of heterozygosity according to the devel-
opment and progression of laryngeal squamous cell carcinoma
(case 2) showing allelic loss (arrow head) from metaplasia (IFNA,
D9S171, D9S104) and from dysplasia (TP53, D3S1038, D3S1067),
Four markers (D3S1234, D8S261, D8S258, D8S133) are homozy-
gote (non-informative).
















Fig. 3. Analysis of loss of heterozygosity according to the develop-
ment and progression of laryngeal squamous cell carcinoma (case
13) showing allelic loss (arrow head) from metaplasia (D9S171),
from dysplasia (D3S1067, D3S1234, D8S133), and from invasive
carcinoma (D8S261, D8S258). Four markers (IFNA, D9S104, TP53,
D3S1038) are homozygote (non-informative).















D8S258dysplasia. In the other 4 cases, LOH was observed in the squa-
mous dysplasia, invasive carcinoma and metastatic carcinoma.
D8S258 also showed no LOH in squamous metaplasia of
all 10 informative cases. 5 (50.0%) of 10 cases showed LOH,
with 4 cases showing LOH in invasive carcinoma and meta-
static carcinoma. In the other case, LOH was shown in squa-
mous dysplasia, invasive carcinoma and metastatic carcino-
ma. Thus, we guess that the tumor suppressor gene is pre-
sumed to be on 8p21.3-p22 and may participate mainly in
the transition stage from preinvasive neoplastic stage to inva-
sive carcinoma. Since the frequency of LOH was the highest
on D8S261 among the 3 markers, we believe that there is a
possibility that the related gene is present near D8S261 (8p22).
DISCUSSION
In the past several years, by comparing and relating the
genetic alterations and histopathological progression in sev-
eral types of tumors, there have been studies on coming up
with a model of tumor development and progression. After
Fearon and Vogelstein (1) first described the molecular genet-
ic progression model of colon cancer, the models of tumor
development and progression on brain tumor and urinary
bladder cancer were also studied (4, 5). Since then, Califarno
et al. have proposed a preliminary model on the progression
of head and neck SCC (6). The chromosomes 9p, 17p, 3p and
8p are where gene losses occur  most frequently in head and
neck SCC. The chromosome 9p21 (7, 8) includes p16INK4a
which encodes the p16, a cyclin dependent kinase inhibitor.
17p13.1 (9, 10) is known as where p53 gene is located on.
The chromosome 3p is where the tumor suppressor gene for
HNSCC is presumed to be located on at least 3 sites (3p25,
3p21, 3p14) (11, 12), and among these 3, there are VHL gene
(3p25) related to von Hippel-Lindau disease (13) and Frag-
ile Histidine Triad (FHIT) gene (3p14.2) (14). Although the
location of the tumor suppressor gene on the chromosome
8p is not clear, Fujiwara et al. (15) suggested that the site
8p21.3-p22 is where the tumor suppressor gene might be
present since it is the site of frequent damages in hepatocel-
lular carcinoma, colon cancer, and non-small cell lung cancer.
The authors of the present study selectively collected the
cells from each histopathological stage of laryngeal SCC, i.e.,
normal, squamous metaplasia, squamous dysplasia, invasive
SCC, and metastatic carcinoma of cervical lymph node, in
the same patients and tried to observe a series of sequential
genetic alterations in these cells. Also, by limiting the study
population to only those with laryngeal SCC, we tried to elimi-
nate possible different effects of different anatomical sites.
LOH of 9p21 was observed from the squamous metaplasia
stage in the majority cases. Thus, we think that the genetic
alterations of 9p21 participate in the early stage of tumori-
genesis where normal cells change to squamous metaplasia
stage. p16INK4a, which is located between IFNA and D9S171
or another tumor suppressor gene around the D9S104 might
be related with squamous metaplasia. This LOH of 9p21 is
also reported in many other solid tumors, such as urinary blad-
der cancer, malignant melanoma, lung cancer, and brain tumor
(16-19), and is reported to play a role in the early stage of
tumor development (18, 20).
LOH on TP53 was shown in 41.2% (7/17). In these cases,
LOH was present in squamous dysplasia, invasive carcinoma
and metastatic carcinoma; thus, we think that the genetic
alteration of 17p13.1 plays a role in the transformation to
preinvasive neoplastic stage. 
As 3p25 and 3p14.2, LOH was observed in the squamous
dysplasia, invasive carcinoma and metastatic carcinoma but
not in the squamous metaplasia. Thus, as same as 17p13.1,
we think that the genetic alterations of 3p25 and 3p14.2
participate in transformation to preinvasive neoplastic stages.
Since the 8p21.3-p22 site is the most frequently damaged
site in hepatocellular carcinoma, colon cancer, and non-small
cell lung carcinoma, it is presumed that at least one tumor
suppressor gene is present on this site (21, 22); and although
Fujiwara et al. (15) mentioned about a tumor suppressor gene
called PDGF receptor beta like tumor suppressor gene, the amino
acid sequence for the gene has not yet known. The markers
for this site, D8S133, D8S261, and D8S258, also did not
show LOH in squamous metaplasia areas. Some cases showed
LOH in squamous dysplasia and other cases in invasive carci-
noma. All these markers showed highly frequent LOH, show-
ing a possible tumor suppressor gene related to SCC at the
8p21.3-p22, and we think that this gene might participate
in the late stage of tumor development, from squamous dys-
plasia to invasive carcinoma. Among the 3 markers, D8S261
showed especially high frequency of LOH, showing a possi-
bility that the related gene might be present near D8S261.
Scholnick et al. (23) reported that genetic alterations of 8p
are related with recurrence or bad prognosis of larynx cancer.
Among the studies on the relationship between genetic
alterations and lymph node metastasis of head and neck SCC,
Ogawara et al. (24) reported that the allelic loss of the chro-
mosome 13q14.3 is related with cervical lymph node metas-
tasis in SCC of oral cavity, whereas Scholnick et al. (23) report-
ed that the chromosomal alterations of 3p, 5q, 8p, 9p, 9q,
13q, and 17p in supraglottic SCC do not have a significant
relationship with lymph node metastasis. Recent study report-
ed evidences for the putative role of RB1 gene alteration in
metastatic process of laryngeal SCC (25). In the present study,
we collected primary carcinoma and metastatic carcinoma
tissue from the same patient, and observed and compared
LOH. In all cases, both primary and metastatic carcinomas
manifested identical patterns of LOH. We think that anoth-
er genetic factor might participate in the process of metasta-
sis of invasive carcinoma.
In laryngeal SCC, clarifying the genetic progression is nec-
essary to understand the development, behavior and progres-
sion of laryngeal SCC. Knowledge on early genetic alterations
LOH in Squamous Cell Carcinoma of the Larynx 349can help the early detection and screening of tumors, and at
the time of tumor resection, by analyzing the molecular bio-
logical state of the cells around the resected area, a more pre-
cise evaluation of the success of resection can be achieved (26).
Also, deciding the molecular biological state in benign muco-
sal epithelium around the invasive carcinoma is important
in predicting whether this area might transform into more
malignant, i.e. invasive carcinoma stage. Veltman et al. (27)
reported chromosomal tetraploidization as an indicator of
malignant progression in laryngeal mucosa. At the same time,
knowledge on genetic alterations of tumor progression can
make a new tumor classification possible by adding a molecu-
lar biological information and may become the basis for gene
therapy in the future. In the present study, we suggest that
9p21 in the early event, 17p13.1, 3p25 and 3p14.2 in the
intermediate event and 8p21.3-p22 in the late event may be
involved in the laryngeal carcinogenesis.
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